Study Groups

Study Acronym Institution Country
Aarhus Prostate Cancer StudyAarhusAarhus University HospitalDenmark
The Agricultural Health StudyAHSNational Cancer Institute, National Institutes of HealthUSA
Australian Prostate Cancer BioResourceAPCBInstitute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, Brisbane, AustraliaMulti Center in Australia
Alpha-Tocopherol Beta-Carotene (BPC3)ATBCNational Cancer Institute, National Institutes of HealthUSA
Genetics of prostate cancer in the BioMe Biobank at the Icahn School of Medicine at Mt. SinaiBIOME-PIcahn School of Medicine at Mount SinaiUSA
BioVUVanderbilt University Medical CenteUSA
Birmingham Prostate Cancer Association StudyBiPASMaastricht UniversityThe Netherlands
Birmingham, The South and East China case control study on prostate and bladder cancerBiSEARCHMaastricht UniversityThe Netherlands
BogdanLabUniversity of California, Los AngelesUSA
BPH eQTLUniversity of Southern CaliforniaUSA
BrazilBrazilBrazil
Canary Prostate Active Surveillance Study (PASS)Canary PASSFred Hutchinson Cancer Research CenterUSA
Cancer of the Prostate in SwedenCAPSKarolinska InstitutetSweden
CardiffCardiff UniversityUK
Cancer Research Initiatives FoundationCARIFUniversity of MalayaMalaysia
Cross Cancer Institute Prostate Brachytherapy CohortCCIAlberta Health ServicesCanada
French Prostate Case-Control StudyCeRePPCentre for Research on Prostatic Diseases (CeRePP)France
ChicagoThe University of ChicagoUSA
Chinese prostate cancer case-control studyCHIPGECSQueen Mary University of London, Second Military Medical University & Wuxi Second HospitalChina
The Consortium of Investigators of Modifiers of BRCA1/2CIMBAUniversity Cambridge, UKUK
CNIOThe Spanish National Cancer Research Center (CNIO)Spain
City Of HopeCOHBeckman Research Institute of the City of HopeUSA
the COhort of Swedish MenCOSMKarolinska InstitutetSweden
Copenhagen Prostate Cancer Study 1CPCS1Herlev University HospitalDenmark
Copenhagen Prostate Cancer Study 2CPCS2Herlev University HospitalDenmark
Uniformed Services University-Center for Prostate Disease ResearchCPDRUniformed Services University – Center for Prostate Disease ResearchUSA
American Cancer Society Cancer Prevention Study-II (BPC3)CPS-IIAmerican Cancer Society, AtlantaUSA
DartmouthDartmouth-Hitchcock Norris Cotton Cancer Center (NCCC)USA
DIScovery of biomarkers for Clinical respOnSE to radiotherapyDISCLOSENational Cancer Centre SingaporeSingapore
EinsteinAlbert Einstein College of MedicineUSA
The Early Onset Prostate Cancer StudyEOPCSThe Cancer Council of VictoriaAustralia
European Prospective Investigation Into Cancer and Nutrition (BPC3)EPICUniversity of OxfordMulti Center in EU
European Prospective Investigation of Cancer – NorfolkEPIC-NorfolkUniversity of CambrigeUK
EPIdemiology of Prostate CAncerEPICAPEnvironmental Cancer Epidemiology, Center for research in epidemiology and population health (CESP) INSERM, Paris-Sud UniversityFrance
European Randomised study of Screening for Prostate CancerERSPCErasmus MCThe Netherlands
Epidemiological investigations of the chances of preventing, recognizing early and optimally treating chronic diseases in an elderly populationESTHERGerman Cancer Research CenterGermany
Fred Hutchinson Prostate Cancer StudiesFHCRCFred Hutchinson Cancer Research CenterUSA
University of Michigan Flint Men’s Health StudyFMHSUniversity of MichiganUSA
Fox ChaseAmerican Oncologic Hospital d/b/a The Hospital of Fox Chase Cancer CenterUSA
Genetic Predictors of Adverse Radiotherapy ResponseGene-PAREIcahn School of Medicine at Mount Sinai (Radiogenomics)USA and Japan
Hamburg-ZagrebUniversity Medical Center Hamburg-EppendorfGermany
Hannover Prostate Cancer StudyHaPCSHannover Biomedical Research SchoolGermany
HarvardDana-Farber Cancer InstituteUSA
Health Professionals Follow-up Study (BPC3) HPFSHarvard School of Public HealthUSA
Prostate ICGC ProjectICGCUniversity of East AngliaUK
Collaborative prostate cancer translational research project: Development of pre-clinical models of disease and non-invasive biomarkers of treatment responseIM.DM.02American University of BeirutLebanon
Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in men at a higher genetic risk and controlsIMPACTThe Institute of Cancer ResearchUK
Innsbruck Medical UniversityInnsbruck Medical UniversityAustria
Portuguese Oncology Institute of PortoIPO-PortoInstituto Portugus de Oncologia do Porto Francisco GentilPortugal
The link between BRCA mutation and endothelial functionIsraelRabin Medical CenterIsrael
The Japan GroupJapanAkita University School of MedicineJapan
French West Indies Prostate cancer StudyKARUPROSTATEUniversity Hospital of Pointe-a-PitreFrance
Regional Cancer Centre, KeralaKeralaRegional Cancer Centre, KeralaIndia
KLK6studyLunenfeld-Tanenbaum Research Institute, Sinai Health SystemCanada
Katholieke Universiteit LeuvenKULEUVENUniversity of LeuvenBelgium
University of Southern California – Los Angeles Prostate Cancer StudyLAAPCUniversity of Southern CaliforniaUSA
Prostate cancer study in MalaysiaMalaysiaUniversity of MalayaMalaysia
Mayo ClinicMAYOMayo ClinicUSA
Multi Case Control Study-SpainMCC-SpainBarcelona Institute for Global Health (ISGlobal)Spain
MCC-Spain-ISCIIIInstituto de Salud Carlos IIISpain
Melbourne Collaborative Cohort StudyMCCSCancer Council VictoriaAustralia
MD AndersonThe University of Texas MD Anderson Cancer CenterUSA
MD Anderson Cancer Center, Active surveillance trialMDACC_ASThe University of Texas, MD Anderson Cancer CenterUSA
Multiethnic Cohort Study (BPC3)MECUniversity of Southern California & University of HawaiUSA
MelbournePeter MacCallum Cancer CentreAustralia
Genetic and non-genetic risk factors for prostate cancer in Mexican men.MexicoInstituto Nacional de Salud PúblicaMexico
MIAMI-WFPCSThe University of Miami – Sylvester Comprehensive Cancer CenterUSA
Identification of novel susceptibility genes for aggressive prostate cancer using genetically diverse miceMMINSGNational Human Genome Research Institute (NHGRI), National Institutes of HealthUSA
The Moffitt GroupMOFFITTH. Lee Moffitt Cancer Center and Research InstituteUSA
The Montreal StudyMontrealMcGill University, MontrealCanada
MSK/OxfordMemorial Sloan Kettering Cancer Center, New YorkUSA
Memorial Sloan-Kettering Cancer CenterMSKCCMemorial Sloan Kettering Cancer Center, New YorkUSA
NCI_VilniusNCI_VilniusNational Cancer Institute-VilniusLithuania
Prostate Cancer Research Group, Nordic EMBL Partnership, Centre for Molecular Medicine NorwayNCMMUniversity of OsloNorway
Nashville Men’s Health StudyNMHSThe Vanderbilt University by and through its Medical CenterUSA
Using rare events modelling and genomic sequencing data to predict devastating outcomes in prostate cancerNOTTINGHAMUniversity of NottinghamUK
Orkney Complex Disease StudyORCADESUsher Institute for Population Health Sciences and Informatics, University of EdinburghUK
COhort of NORway (CONOR)OsloOslo University HospitalNorway
Prostate Cancer, Obesity and associated factors: Case-Control Study of Health Areas of Burgos and LeónPaCO-BaLePreventive Medicine and Public Health, University of León, SpainSpain
North Carolina – Louisiana Prostate Cancer Project ConsortiumPCaPThe University of North Carolina at Chapel HillUSA
Prostate Cancer Case control study in PakistanPCCCSPLiaquat University of Medical and Health SciencesIndia
Prostate Cancer Genetics ProjectPCGPUniversity of MichiganUSA
Prostate Cancer study Medical University SofiaPCMUSMedical University of SofiaBulgaria
Prostate Cancer Research Consortium, IrelandPCRCSt James’s University Hospital, DublinIreland
Study of Clinical Outcomes Risk and Ethnicity (SCORE) at the University of PennsylvaniaPENNCenter for Clinical Epidemiology and Biostatistics University of PennsylvaniaUSA
PHRC Prostate 2005PHRCUniversity MontpellierFrance
Physicians Health Study (BPC3)PHSBrigham and Women’s HospitalUSA
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (BPC3)PLCONational Cancer Institute, National Institutes of HealthUSA
The Poland GroupPolandPomeranian Medical University, SzczecinPoland
Prostate Project Foundation – Postgraduate Medical School, SurreyPPF-UNISThe University of SurreyUK
PRostate cAncer Genetics in GaliciaPRAGGAGalician Foundation of Genomic Medicine, Santiago de CompostelaSpain
PROgression in CAncer of the ProstatePROCAPKarolinska InstitutetSweden
Germline genetic profiling: correlation with targeted prostate cancer screening and treatment – The Pilot Profile StudyPROFILEThe Institute of Cancer ResearchUK
Prostate Cancer Group, Santiago, SpainPROGReSSFundacion Publica Gallega Medicina Xenomica, Santiago de CompostelaSpain
Prostate cancer : Mechanisms of progression and TreatmentProMPTUniversity of Cambridge, University of Bristol & University of OxfordUK
SNPs and prostate cancer risk in Serbian populationPROSTATSERBIACenter for Human Molecular Genetics, University of BelgradeSerbia
Prostate testing for cancer and TreatmentProtecTUniversity of Cambridge, University of Bristol & University of OxfordUK
Prostate Cancer and Environment StudyPROtEuSInstitut national de la recherche scientifiqueCanada
Prostate Cancer Supportive Care and Patient Outcomes Project (ProsCan), The QldMen and the Red Cross studyQLDQueensland University of TechnologyAustralia
Radiogenomics: Assessment of Polymorphisms for Predicting the Effects of RadiotherapyRAPPERThe University of ManchesterUK
Risk Factors for Prostate Cancer StudyRFPCSThe Cancer Council of VictoriaAustralia
RIKEN Center for Integrative Medical SciencesRIKENThe University of TokyoJapan
Roosevelt HospitalRooseveltSt. Luke’s-Roosevelt Hospital Center, New YorkUSA
San Antonio Center of Biomarkers of Risk for Prostate CancerSABORThe University of Texas Health Science Center at San AntonioUSA
Southern Community Cohort StudySCCSVanderbilt UniversityUSA
South Carolina Prostate Cancer StudySCPCSMeharry Medical CollegeUSA
Study of Epidemiology and Risk factors in Cancer HereditySEARCHUniversity of CambridgeUK
SELECTCleveland Clinic Lerner College of MedicineUSA
San Francisco Bay Area Prostate Cancer Study (former NC_CCPC)SFPCSCancer Prevention Institute of California and Stanford University School of MedicineUSA
SNP Prostate GhentSNP_Prostate_GhentThe Ghent UniversityBelgium
Serum Proteomic analysis for biomarkers of Aggressive prostate disease in the Guernsey populationSPAGThe University of SurreyUK
St GeorgesSt George’s, University of LondonUK
Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug EfficacySTAMPEDEMRC Clinical Trials Unit at UCL, University College LondonUK
Stanford University School of MedicineStanfordStanford University School of MedicineUSA
Stockholm 1STHM1Karolinska InstitutetSweden
Stockholm 2STHM2Karolinska InstitutetSweden
Sweeney_DFCIDana Farber Cancer InstituteUSA
Prostate Cancer Prevention TrialSWOG-PCPTSWOG Statistical Center, Fred Hutchinson Cancer Research CenterUSA
Selenium and Vitamin E Cancer Prevention TrialSWOG-SELECTSWOG Statistical Center, Fred Hutchinson Cancer Research CenterUSA
Finnish Genetic Predisposition to Prostate Cancer StudyTAMPEREUniversity of TampereFinland
TASPRAC StudyTASPRACUniversity of TasmaniaAustralia
Prostate Cancer Study in Tata Memorial Centre, Navi MumbaiTMCTata Memorial Centre, Navi MumbaiIndia
Princess Margaret Biopsy DatabaseTorontoPrincess Margaret Hospital, TorontoCanada
Practical study of TurkeyTuPracticalBezmialem Vakif UniversityTurkey
UC San Diego (UCSD)UCSDUniversity of California, San DiegoUSA
UGANDAMakerere University, Kampala, UgandaUganda
U.K. Genetic Prostate Cancer Study and The Prostate Cancer Research Foundation StudyUKGPCSThe Institute of Cancer ResearchUK
Familial Prostate Cancer Study GermanyULMUniversity Hospital of UlmGermany
University of Southern California – Los Angeles Prostate Cancer StudyUSCUniversity of Southern CaliforniaUSA
UTAH StudyUTAHUniversity of UtahUSA
Prostate Cancer Study in ValaisValaisHopital Cantonal Universitaire de GeneveSwitzerland
Wedge_groupUniversity of OxfordUK
Wake Forest Baptist Medical CenterWFUBMCWake Forest University School of MedicineChina
Washington University Genetics StudyWUGSWashington University School of MedicineUSA